These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 4619567

  • 1. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ.
    Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
    [No Abstract] [Full Text] [Related]

  • 2. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ.
    Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
    [No Abstract] [Full Text] [Related]

  • 3. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) I. Clinical course].
    Horsfall PA.
    Bull Int Union Tuberc; 1974; 49(1):447-51. PubMed ID: 4619566
    [No Abstract] [Full Text] [Related]

  • 4. Controlled clinical evaluation of three intermittent regimens employing low-dosage schedules of rifampicin in original treatment of pulmonary tuberculosis. Preliminary data on effectiveness and side effects.
    Nitti V.
    Scand J Respir Dis Suppl; 1973; 84():180-5. PubMed ID: 4593266
    [No Abstract] [Full Text] [Related]

  • 5. Clinical aspects of side effects on intermittent rifampicin regimen.
    Zierski M.
    Scand J Respir Dis Suppl; 1973; 84():166-73. PubMed ID: 4522072
    [No Abstract] [Full Text] [Related]

  • 6. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions.
    Girling DJ.
    Scand J Respir Dis Suppl; 1973; 84():119-24. PubMed ID: 4522064
    [No Abstract] [Full Text] [Related]

  • 7. The intermittent chemotherapy of tuberculosis with rifampicin regimens on ambulatory basis.
    Anastasatu C, Bungeteanu G, Sibila S.
    Scand J Respir Dis Suppl; 1973; 84():136-9. PubMed ID: 4522068
    [No Abstract] [Full Text] [Related]

  • 8. Preliminary results of a controlled therapeutic trail administering INH-RMP once-weekly, after--or without--an initial period of continuous treatment.
    Eule H, Kärnbach E, Kaluza P, Herrmann H.
    Scand J Respir Dis Suppl; 1973; 84():153-9. PubMed ID: 4593264
    [No Abstract] [Full Text] [Related]

  • 9. Therapeutic effects and side effects of rifampicin administered daily or twice-weekly.
    Gomi J, Aoyagi T.
    Scand J Respir Dis Suppl; 1973; 84():145-52. PubMed ID: 4522070
    [No Abstract] [Full Text] [Related]

  • 10. Intermittent rifampicin treatment of tuberculosis.
    Riska N, Mattson K.
    Scand J Respir Dis Suppl; 1973; 84():140-4. PubMed ID: 4522069
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Side effects observed during intermittent rifampicin therapy.
    Stradling P.
    Scand J Respir Dis Suppl; 1973; 84():129-31. PubMed ID: 4522066
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
    Masztalerz J.
    Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
    Mavrotskiĭ VV.
    Klin Med (Mosk); 1974 Dec; 52(12):31-4. PubMed ID: 4444241
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A comparative study of daily followed by twice or once weekly regimens of ethambutol and rifampicin in retreatment of patients with pulmonary tuberculosis. The results at 1 year. A cooperative tuberculosis chemotherapy study in Poland.
    Tubercle; 1975 Mar; 56(1):1-26. PubMed ID: 1096388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.